Method of treating rhinitis or sinusitis by intranasally administering a peptidase
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jan 8, 2002
Grant Date -
N/A
app pub date -
Feb 28, 2001
filing date -
Feb 28, 2001
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The present invention is directed to methods of treating mucosal inflammation associated with rhinitis or sinusitis by administering peptidases that recognize and cleave polypeptides at Xaa-Pro sequences. In addition, the invention encompasses therapeutic packages in which pharmaceutical compositions containing the peptidases are preloaded in a device suitable for intranasally delivering drug.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully